Full Text of SB2131 99th General Assembly
SB2131 99TH GENERAL ASSEMBLY
99TH GENERAL ASSEMBLY
State of Illinois
2015 and 2016
Introduced 5/6/2015, by Sen. Dan Kotowski
SYNOPSIS AS INTRODUCED:
Amends the Pharmacy Practice Act. Provides that pharmacists may not
interchange an atypical anti-psychotic drug or targeted immune modulator
without notification and documented consent by the prescribing
practitioner and the patient or patient's parent, legal guardian, or
spouse. Provides that if the pharmacist does substitute a drug, then the
pharmacist shall provide written notice to the patient no later than the
time the prescription is dispensed. Provides that these provisions shall
not be construed to prohibit generic drug substitution as provided for in
the Pharmacy Practice Act. Effective immediately.
A BILL FOR
|SB2131||LRB099 12255 MLM 35166 b|
AN ACT concerning regulation.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
The Pharmacy Practice Act is amended by changing
Section 26 as follows:
(225 ILCS 85/26)
(Section scheduled to be repealed on January 1, 2018)
, atypical anti-psychotic, and
targeted immune modulator (TIM)
(a) The General Assembly finds that this Section is
necessary for the immediate preservation of the public peace,
health, and safety.
(b) In this Section:
"Anti-epileptic drug" means (i) any drug prescribed for the
treatment of epilepsy or (ii) a drug used to treat or prevent
"Epilepsy" means a neurological condition characterized by
"Seizure" means a brief disturbance in the electrical
activity of the brain.
(c) When the prescribing physician has indicated on the
original prescription "may not substitute", a pharmacist may
|SB2131||- 2 -||LRB099 12255 MLM 35166 b|
not interchange an anti-epileptic drug or formulation of an
anti-epileptic drug for the treatment of epilepsy
, an atypical
anti-psychotic drug, or targeted immune modulator (TIM)
without notification and the documented consent of the
and the patient or the
patient's parent, legal guardian, or spouse.
This Section does
not apply to medication orders issued for anti-epileptic drugs
atypical anti-psychotic drugs, or targeted immune modulators
for any in-patient care in a licensed hospital.
(d) If a pharmacist substitutes any
anti-psychotic drug, or targeted immune modulator,
pharmacist shall provide written notice to the patient no later
than the time the prescription is dispensed.
(e) Nothing in this Section shall be construed to prohibit
generic drug substitution as provided for in Section 25 of this
(Source: P.A. 97-456, eff. 1-1-12.)
This Act takes effect upon